Cargando…

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy

Background. Parkinson's disease (PD) remains a clinical diagnosis and biomarkers are needed to detect the disease as early as possible. Genetically determined PD provides an opportunity for studying metabolic differences in connection with disease development. Objectives. To study the levels of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aasly, Jan O., Sæther, Oddbjørn, Johansen, Krisztina K., Bathen, Tone F., Giskeødegård, Guro F., White, Linda R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556333/ https://www.ncbi.nlm.nih.gov/pubmed/26357583 http://dx.doi.org/10.1155/2015/264896

Ejemplares similares

Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples
por: Haukaas, Tonje H., et al.
Publicado: (2017)

The association between circulating lipoprotein subfractions and lipid content in coronary atheromatous plaques assessed by near-infrared spectroscopy
por: Sæther, Julie Caroline, et al.
Publicado: (2023)

Effect of Delayed Centrifugation on the Levels of NMR-Measured Lipoproteins and Metabolites in Plasma and Serum Samples
por: Debik, Julia, et al.
Publicado: (2022)

Metabolomic Profiling in LRRK2-Related Parkinson's Disease
por: Johansen, Krisztina K., et al.
Publicado: (2009)

Longitudinal Changes in Circulating Metabolites and Lipoproteins After Breast Cancer Treatment
por: Giskeødegård, Guro F., et al.
Publicado: (2022)

Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson’s Disease: A Pilot Study
por: Yilmaz, Ali, et al.
Publicado: (2020)

Lipoprotein subfraction profiling in the search of new risk markers for myocardial infarction: The HUNT study
por: Sperstad, Sigri Bakken, et al.
Publicado: (2023)

Serum Levels of Choline-Containing Compounds Are Associated with Aerobic Fitness Level: The HUNT-Study
por: Bye, Anja, et al.
Publicado: (2012)

Association of serum metabolome profile with the risk of breast cancer in participants of the HUNT2 study
por: Mrowiec, Katarzyna, et al.
Publicado: (2023)

Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T
por: Sjøbakk, Torill E, et al.
Publicado: (2007)

Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease
por: Warø, Bjørg Johanne, et al.
Publicado: (2017)

Metabolic characterization of triple negative breast cancer
por: Cao, Maria D, et al.
Publicado: (2014)

Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
por: Madssen, Torfinn S., et al.
Publicado: (2018)

Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
por: Smith, G. A., et al.
Publicado: (2015)

Historical Biobanks in Breast Cancer Metabolomics— Challenges and Opportunities
por: Madssen, Torfinn S., et al.
Publicado: (2019)

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
por: Cao, Maria D, et al.
Publicado: (2012)

Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies
por: Haukaas, Tonje H., et al.
Publicado: (2016)

Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins
por: Torkildsen, Cecilie Fredvik, et al.
Publicado: (2023)

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?
por: Loeffler, David A., et al.
Publicado: (2019)

Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
por: Wang, Shijie, et al.
Publicado: (2017)

Simultaneous Detection of Zinc and Its Pathway Metabolites Using MALDI MS Imaging of Prostate Tissue
por: Andersen, Maria K., et al.
Publicado: (2020)

Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery
por: Bathen, Tone F., et al.
Publicado: (2013)

Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma
por: Andersen, Maria K., et al.
Publicado: (2018)

Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy
por: van Asten, Jack JA, et al.
Publicado: (2015)

Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3
por: Okubadejo, Njideka, et al.
Publicado: (2008)

Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
por: Kim, Hongwon, et al.
Publicado: (2019)

Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
por: Aasly, Jan O., et al.
Publicado: (2014)

Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
por: Giskeødegård, Guro F., et al.
Publicado: (2013)

Evaluating the Impact of High Intensity Interval Training on Axial Psoriatic Arthritis Based on MR Images
por: Chronaiou, Ioanna, et al.
Publicado: (2022)

The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics features
por: Dewi, Dyah Ekashanti Octorina, et al.
Publicado: (2023)

Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
por: Aasly, Jan O.
Publicado: (2021)

Association of serum cortisol and cortisone levels and risk of recurrence after endocrine treatment in breast cancer
por: Wang, Feng, et al.
Publicado: (2023)

Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease
por: Flinkman, Dani, et al.
Publicado: (2023)

Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients
por: Dong, Chen, et al.
Publicado: (2022)

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
por: Giskeødegård, Guro F, et al.
Publicado: (2015)

Allosteric inhibition of a stem cell RNA-binding protein by an intermediary metabolite
por: Clingman, Carina C, et al.
Publicado: (2014)

Ataxia with Vitamin E Deficiency in Norway
por: Elkamil, Areej, et al.
Publicado: (2015)

Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population
por: Fang, Jie, et al.
Publicado: (2016)

Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry
por: Romero-Gutiérrez, Elizabeth, et al.
Publicado: (2021)

Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations
por: Loeffler, David A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_db40tov5rbn26ldch95ko50mv8